Clomevac 50 Tablet
Clomevac 50 Tablet is a medicine used to treat female infertility. It is used in women who are unable to become pregnant, due to ovulation problems or suffering from polycystic ovary syndrome (PCOS).
Clomevac 50 Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Clomevac 50 Tablet is a medicine used to treat female infertility. It is used in women who are unable to become pregnant, due to ovulation problems or suffering from polycystic ovary syndrome (PCOS).
Clomevac 50 Tablet is a medicine used to treat female infertility. It is used in women who are unable to become pregnant, due to ovulation problems or suffering from polycystic ovary syndrome (PCOS).
Take Clomevac 50 Tablet exactly as prescribed by the doctor. It is usually taken for a few days at the beginning of the menstrual cycle. Regular monitoring, including ultrasound scans or hormone level tests, may be needed to track ovulation. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can further improve the chances of pregnancy while on this medication.
The most common side effects associated with this medicine are hot flushes (red and warm face), stomach discomfort, breast pain, and visual disturbances. Most of these symptoms are temporary. However, if they persist, consult your doctor as soon as possible.
Inform your doctor before taking Clomevac 50 Tablet if you have any issues with the liver, kidney, or heart, and if you are pregnant. Additionally, tell your doctor if you are taking any medicine or supplement before starting Clomevac 50 Tablet.
03Uses
Female infertility
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Clomevac 50 Tablet may be taken with or without food, but it is better to take it at a fixed time.
05How It Works
Clomevac 50 Tablet is a selective estrogen receptor modulator (SERM) that treats female infertility. It works by promoting the release of reproductive hormones. This helps stimulate the release of eggs from the ovary (ovulation).
06What If You Miss A Dose?
Q: What if you forget to take Clomevac Tablet?
A: If you miss a dose of Clomevac 50 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Side Effects
Vomiting
Bloating
Headache
Enlarged ovary
Metrorrhagia (menstrual bleeding at irregular intervals)
Nausea
Hot flashes
Breast discomfort
Visual disorder
08Safety Information
Alcohol:CAUTION
Caution is advised when consuming alcohol with Clomevac 50 Tablet. Please consult your doctor.
Pregnancy:UNSAFE
Clomevac 50 Tablet is highly unsafe to use during pregnancy. Seek your doctor’s advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding:CONSULT YOUR DOCTOR
Clomevac 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:UNSAFE
Clomevac 50 Tablet may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Clomevac 50 Tablet in patients with kidney disease. Please consult your doctor.
Liver:UNSAFE
Clomevac 50 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
09Drug Tips
Clomevac 50 Tablet is not safe for long-term use. Hence, it is advisable not to use it for more than 3 menstrual cycles.
The medicine will cause ovulation after 5-10 days. It is advisable to have regular intercourse during this period.
It may cause blurring of vision. Be cautious while driving or doing anything requiring mental focus.
Inform your doctor if you experience abdominal pain and distention, nausea, vomiting, diarrhea, and weight gain while taking this medicine.
References
Sources and references
Schimmer BP, Parker KL. Contraception and Pharmacotherapy of Obstetrical and Gynecological Disorders. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1841-43.
Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 718-19.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 296-98.
Clomifene citrate [EMC SmPC]. Reading, Berkshire: Sanofi; 2019. [Accessed 30 Jan. 2020] (online) Available from: View
Clomiphene citrate [FDA Label]. Bridgewater, NJ: Sanofi-Aventis U.S. LLC; 2012. [Accessed 30 Jan. 2020] (online) Available from: View
Clomifene citrate [Package Information Leaflet]. Reading, Berkshire: Sanofi; 2019. [Accessed 30 Jan. 2020] (online) Available from: View
CiplaMed. Clomiphene citrate [Prescribing Information]. [Accessed 25 Jul. 2024] (online) Available from: View
Clomifene citrate [Summary of Product Characteristics]. Gentilly, France: Sanofi-Aventis France; 2018. [Accessed 05 Mar. 2025] (online) Available from: View
Clomiphene citrate [Summary of Product Characteristics]. Alwar, Rajasthan: Gracure Pharmaceuticals Ltd.; 2019. [Accessed 05 Mar. 2025] (online) Available from: View
